Ascilion provides painless extraction and analysis of interstitial fluid with hollow microneedles.
Ascilion has raised $2.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
Ascilion's investors include Lotus One Investment, Nordstjernan.
Ascilion is headquartered in Stockholm, Sweden.
Ascilion provides painless extraction and analysis of interstitial fluid with hollow microneedles.
Ascilion is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ascilion — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/ascilion. Accessed July 19, 2026.
VCBacked. (2025). Ascilion — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/ascilion
{{cite web |title=Ascilion — Funding & Investors |url=https://www.vcbacked.co/company/ascilion |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated